Literature DB >> 26601438

Bluetongue.

N J Maclachlan, C E Mayo, P W Daniels, G Savini, S Zientara, E P J Gibbs.   

Abstract

Summary Bluetongue (BT) is an arthropod-transmitted viral disease of non-African ungulates, principally sheep. The disease results from vascular injury analogous to that of human haemorrhagic viral fevers, with characteristic tissue infarction, haemorrhage, vascular leakage, oedema, and hypovolaemic shock. Importantly, BT is not zoonotic. Bluetongue virus (BTV) infection of ruminants and vector Culicoides midges is endemic throughout many tropical and temperate regions of the world; however, within this global range the virus exists within relatively discrete ecosystems (syn. episystems) where specific constellations of BTV serotypes are spread by different species of biting Culicoides midges. Recently discovered goat-associated BTVs, notably BTV serotype 25 (BTV-25) in central Europe, appear to have distinctive biological properties and an epidemiology that is not reliant on Culicoides midges as vectors for virus transmission. Bluetongue virus infection of ruminants is often subclinical, but outbreaks of severe disease occur regularly at the upper and lower limits of the virus's global range, where infection is distinctly seasonal. There have been recent regional alterations in the global distribution of BTV infection, particularly in Europe. It is proposed that climate change is responsible for these events through its impact on vector midges. However, the role of anthropogenic factors in mediating emergence of BTV into new areas remains poorly defined; for example, it is not clear to what extent anthropogenic factors were responsible for the recent translocation to northern and eastern Europe of live attenuated vaccine viruses and an especially virulent strain of BTV-8 with distinctive properties. Without thorough characterisation of all environmental and anthropogenic drivers of the recent emergence of BT in northern Europe and elsewhere, it is difficult to predict what the future holds in terms of global emergence of BTV infection. Accurate and convenient laboratory tests are available for the sensitive and specific serological and virological diagnosis of BTV infection and confirmation of BT in animals. Prevention and control strategies for BT are largely reactive in nature, and typically are reliant on vaccination of susceptible livestock and restrictions on animal trade and movement.

Entities:  

Mesh:

Year:  2015        PMID: 26601438     DOI: 10.20506/rst.34.2.2360

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  21 in total

1.  Full genome sequence of a Sathuvachari virus strain isolated in the southwestern-most archipelago of Japan.

Authors:  Tomoko Kato; Maki Aizawa; Katsunori Takayoshi; Tohru Yanase; Shogo Tanaka; Hiroaki Shirafuji; Makoto Yamakawa
Journal:  Virus Genes       Date:  2018-08-01       Impact factor: 2.332

2.  Bluetongue Virus Infection of Goats: Re-Emerged European Serotype 8 vs. Two Atypical Serotypes.

Authors:  Christina Ries; Martin Beer; Bernd Hoffmann
Journal:  Viruses       Date:  2022-05-13       Impact factor: 5.818

3.  Risk-based serological survey of bluetongue and the first evidence of bluetongue virus serotype 26 circulation in Tunisia.

Authors:  Kalthoum Sana; Sghaier Soufien; Ben Hassine Thameur; Teodori Liana; Spedicato Massimo; Guesmi Kaouther; Gharbi Raja; Hajlaoui Haikel; Bel Haj Mohamed Bassem; Khalfaoui Wiem; Lachtar Monia; Ben Salem Ameni; Fatnassi Naouel; Dhaouadi Anissa; Ben Ali Mehdi; Thabet Sarah; Seghaier Chedia; Savini Giovanni; Hammami Salah
Journal:  Vet Med Sci       Date:  2022-05-05

4.  A Deterministic Model to Quantify Risk and Guide Mitigation Strategies to Reduce Bluetongue Virus Transmission in California Dairy Cattle.

Authors:  Christie Mayo; Courtney Shelley; N James MacLachlan; Ian Gardner; David Hartley; Christopher Barker
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

5.  Seroprevalence of Q Fever, Brucellosis, and Bluetongue in Selected Provinces in Lao People's Democratic Republic.

Authors:  Bounlom Douangngeun; Watthana Theppangna; Vilayvahn Soukvilay; Chanthana Senaphanh; Kamphok Phithacthep; Souk Phomhaksa; Samuel Yingst; Eric Lombardini; Eric Hansson; Paul W Selleck; Stuart D Blacksell
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

6.  Sellers' Revisited: A Big Data Reassessment of Historical Outbreaks of Bluetongue and African Horse Sickness due to the Long-Distance Wind Dispersion of Culicoides Midges.

Authors:  Peter A Durr; Kerryne Graham; Rieks D van Klinken
Journal:  Front Vet Sci       Date:  2017-07-20

7.  Sampling Methodology to Maximize the Efficient Use of National Abattoir Surveillance: Using Archived Sera to Substantiate Freedom From Bluetongue Virus Infection in Ireland.

Authors:  Jamie A Tratalos; Damien J Barrett; Tracy A Clegg; Ronan G O'Neill; Guy McGrath; Elizabeth A Lane; Simon J More
Journal:  Front Vet Sci       Date:  2018-10-24

8.  CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR-/- Mice.

Authors:  Alejandro Marín-López; Eva Calvo-Pinilla; Diego Barriales; Gema Lorenzo; Alejandro Brun; Juan Anguita; Javier Ortego
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

9.  Environment, vector, or host? Using machine learning to untangle the mechanisms driving arbovirus outbreaks.

Authors:  Moh A Alkhamis; Nicholas M Fountain-Jones; Cecilia Aguilar-Vega; José M Sánchez-Vizcaíno
Journal:  Ecol Appl       Date:  2021-08-23       Impact factor: 6.105

10.  African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.

Authors:  Camilla T Weyer; John D Grewar; Phillippa Burger; Esthea Rossouw; Carina Lourens; Christopher Joone; Misha le Grange; Peter Coetzee; Estelle Venter; Darren P Martin; N James MacLachlan; Alan J Guthrie
Journal:  Emerg Infect Dis       Date:  2016-12-15       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.